Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2009 Aug;25(8):453.
doi: 10.1016/s0828-282x(09)70133-3.

Alternate day dosing of rosuvastatin: potential usefulness in statin-intolerant patients

Tisha Joy, Robert A Hegele
Clinical Trial

Alternate day dosing of rosuvastatin: potential usefulness in statin-intolerant patients

Tisha Joy et al. Can J Cardiol. 2009 Aug.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Dulay D, LaHaye SA, Lahey KA, Day AG. Efficacy of alternate day versus daily dosing of rosuvastatin. Can J Cardiol. 2009;25:e28–31. - PMC - PubMed
    1. Bays H. Statin safety: An overview and assessment of the data – 2005. Am J Cardiol. 2006;97:6C–26C. - PubMed
    1. Law M, Rudnicka AR. Statin safety: A systematic review. Am J Cardiol. 2006;97:52C–60C. - PubMed
    1. Bruckert E, Hayem G, Dejager S, Yau C, Begaud B. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients – the PRIMO study. Cardiovasc Drugs Ther. 2005;19:403–14. - PubMed
    1. Nichols GA, Koro CE. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients. Clin Ther. 2007;29:1761–70. - PubMed

MeSH terms